Trial intelligence / Profile preview

Ibuprofen Sustained Release Premedication for Pain in Root Canal Treatment

NCT05053009Unknown

Sponsor
Cairo University
Start
Nov 2021
Primary completion
Oct 2022
Modality
Small Molecules
01

Overview

Randomised, double-blind trial in irreversible pulpitis and apical periodontitis (AP) comparing Ibuprofen SR with Placebo (2 arms). Primary endpoint: Efficacy of buccal infiltration anaesthesia. Status: unknown.

02

Drugs

ibuprofen
03

Conditions

irreversible pulpitisapical periodontitis (AP)

Beyond the preview

Go deeper on NCT05053009.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05053009.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call